Dublin, May 21, 2026 (GLOBE NEWSWIRE) -- The "Upstream and Downstream Manufacturing in the Biopharmaceutical Industry (June 11, 2026)" training has been added to ResearchAndMarkets.com's offering.

The intensification of upstream bioprocessing sounds daring, as though it were equivalent to flooring a car’s accelerator pedal and pushing the tachometer into the red zone. But with the right ...

Further to Decision 46 COM 9A, this document presents a report on the implementation of the Upstream Process requests since the 46th session of the World Heritage Committee (New Delhi, 2024). It also ...

Regulatory approval is only one marker of success for biotherapeutics. Biotherapeutics must also be commercially feasible. Too high a price tag can lead to limited availability to the targeted patient ...